BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17461423)

  • 1. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
    Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
    Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New protocol for lentiviral vector mass production.
    Segura MM; Garnier A; Durocher Y; Ansorge S; Kamen A
    Methods Mol Biol; 2010; 614():39-52. PubMed ID: 20225034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of retrovirus particles using heparin affinity chromatography.
    Segura MM; Kamen A; Garnier A
    Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
    Kuroda H; Kutner RH; Bazan NG; Reiser J
    J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine-based transfection method as a simple and effective way to produce recombinant lentiviral vectors.
    Toledo JR; Prieto Y; Oramas N; Sánchez O
    Appl Biochem Biotechnol; 2009 Jun; 157(3):538-44. PubMed ID: 19089654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
    Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
    Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
    Segura MM; Kamen A; Garnier A
    Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel system for producing lentiviral vectors].
    Ma Q; Li M; Dong WQ; Wu YS
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):958-60. PubMed ID: 18051882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
    Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
    Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized production and concentration of lentiviral vectors containing large inserts.
    al Yacoub N; Romanowska M; Haritonova N; Foerster J
    J Gene Med; 2007 Jul; 9(7):579-84. PubMed ID: 17533614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and purification of lentiviral vectors.
    Tiscornia G; Singer O; Verma IM
    Nat Protoc; 2006; 1(1):241-5. PubMed ID: 17406239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
    Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
    Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
    Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
    Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of lentiviral vectors in protein-free media.
    Kuroda H; Marino MP; Kutner RH; Reiser J
    Curr Protoc Cell Biol; 2011 Mar; Chapter 26():Unit 26.8. PubMed ID: 21400699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalable production of adeno-associated virus type 2 vectors via suspension transfection.
    Park JY; Lim BP; Lee K; Kim YG; Jo EC
    Biotechnol Bioeng; 2006 Jun; 94(3):416-30. PubMed ID: 16622883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using an EGFPmeter to evaluate the lentiviral vector production: tricks and traps.
    Bagnis C; Bailly P; Chapel-Fernandes S
    Methods Mol Biol; 2009; 515():151-63. PubMed ID: 19378135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.
    Scherr M; Battmer K; Eder M; Schüle S; Hohenberg H; Ganser A; Grez M; Blömer U
    Gene Ther; 2002 Dec; 9(24):1708-14. PubMed ID: 12457285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.
    Zhang B; Xia HQ; Cleghorn G; Gobe G; West M; Wei MQ
    Gene Ther; 2001 Nov; 8(22):1745-51. PubMed ID: 11892843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.